Wingtech Technology establishes independent management for Nexperia's Chinese unit, ensuring operational autonomy amid a dispute with Nexperia's Dutch headquarters over control and operations.
Shenzhen-based Wingtech has sued in a Guangdong court, demanding restoration of control over Nexperia and 8 billion yuan in compensation, after the Dutch government's September 2025 order to seize control was suspended but left Wingtech's control "restricted".
Der chinesische Wingtech-Konzern hat seine Tochterfirma Nexperia und drei Topmanager wegen angeblicher Verstöße gegen chinesisches Recht und finanzieller Schäden verklagt. Die Klage, die in China eingereicht wurde, fordert rund eine Milliarde Euro Schadenersatz.
Wingtech Technology faces a delisting risk warning on the Shanghai Stock Exchange after its auditor issued a disclaimer of opinion regarding Nexperia's financial records. The company has until the end of 2026 to resolve the audit issues.
